North American Neuromodulation Market
The North American Neuromodulation Market size was valued at US$ 3,029.72 Mn in 2019 and is projected to reach US$ 6,612.00 Mn by 2027, growing at a CAGR of 10.6% during 2020 - 2027.
Report Coverage
- Technology: External Neuromodulation, Internal Neuromodulation
- Application: Chronic Pain Management, Failed Back Syndrome, Epilepsy, Tremor, Incontinence, Depression, Dystonia, Gastroparesis, Parkinson's Disease, Obsessive-Compulsive Disorder, Migraine
- End User: Hospitals, Clinics, Home Healthcare
US$ 3,029.72 Mn
Market size in 2019
US$ 6,612.00 Mn
Market Size by 2027
10.6%
CAGR, 2020 - 2027
2020-2027
Forecast Period
1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. North American Neuromodulation Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. North American Neuromodulation Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. North American Neuromodulation Market Regional Analysis
6.2 North American Neuromodulation Market Revenue 2017-2027 (US$ Million)
6.3 North American Neuromodulation Market Forecast Analysis
7. North American Neuromodulation Market Analysis – by Technology
7.1 External Neuromodulation
- 7.1.1 Overview
- 7.1.2 External Neuromodulation: North American Neuromodulation Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.2 Internal Neuromodulation
- 7.2.1 Overview
- 7.2.2 Internal Neuromodulation: North American Neuromodulation Market – Revenue and Forecast, 2017-2027 (US$ Million)
8. North American Neuromodulation Market Analysis – by Application
8.1 Chronic Pain Management
- 8.1.1 Overview
- 8.1.2 Chronic Pain Management: North American Neuromodulation Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.2 Failed Back Syndrome
- 8.2.1 Overview
- 8.2.2 Failed Back Syndrome: North American Neuromodulation Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.3 Epilepsy
- 8.3.1 Overview
- 8.3.2 Epilepsy: North American Neuromodulation Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.4 Tremor
- 8.4.1 Overview
- 8.4.2 Tremor: North American Neuromodulation Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.5 Incontinence
- 8.5.1 Overview
- 8.5.2 Incontinence: North American Neuromodulation Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.6 Depression
- 8.6.1 Overview
- 8.6.2 Depression: North American Neuromodulation Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.7 Dystonia
- 8.7.1 Overview
- 8.7.2 Dystonia: North American Neuromodulation Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.8 Gastroparesis
- 8.8.1 Overview
- 8.8.2 Gastroparesis: North American Neuromodulation Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.9 Parkinson's Disease
- 8.9.1 Overview
- 8.9.2 Parkinson's Disease: North American Neuromodulation Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.10 Obsessive-Compulsive Disorder
- 8.10.1 Overview
- 8.10.2 Obsessive-Compulsive Disorder: North American Neuromodulation Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.11 Migraine
- 8.11.1 Overview
- 8.11.2 Migraine: North American Neuromodulation Market – Revenue and Forecast, 2017-2027 (US$ Million)
9. North American Neuromodulation Market Analysis – by End User
9.1 Hospitals
- 9.1.1 Overview
- 9.1.2 Hospitals: North American Neuromodulation Market – Revenue and Forecast, 2017-2027 (US$ Million)
9.2 Clinics
- 9.2.1 Overview
- 9.2.2 Clinics: North American Neuromodulation Market – Revenue and Forecast, 2017-2027 (US$ Million)
9.3 Home Healthcare
- 9.3.1 Overview
- 9.3.2 Home Healthcare: North American Neuromodulation Market – Revenue and Forecast, 2017-2027 (US$ Million)
10. North American Neuromodulation Market – North America Analysis
10.1 Overview
10.2 North America- 10.2.1 North American Neuromodulation Market Breakdown, by Key Country, 2020 and 2027 (%)
- 10.2.1.1 North American Neuromodulation Market – Revenue and Forecast Analysis – by Country
- 10.2.1.1 US: North American Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.1.1 US: North American Neuromodulation Market Breakdown, by Technology
- 10.2.1.1.2 US: North American Neuromodulation Market Breakdown, by Application
- 10.2.1.1.3 US: North American Neuromodulation Market Breakdown, by End User
- 10.2.1.2 Canada: North American Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.2.1 Canada: North American Neuromodulation Market Breakdown, by Technology
- 10.2.1.2.2 Canada: North American Neuromodulation Market Breakdown, by Application
- 10.2.1.2.3 Canada: North American Neuromodulation Market Breakdown, by End User
- 10.2.1.3 Mexico : North American Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.3.1 Mexico : North American Neuromodulation Market Breakdown, by Technology
- 10.2.1.3.2 Mexico : North American Neuromodulation Market Breakdown, by Application
- 10.2.1.3.3 Mexico : North American Neuromodulation Market Breakdown, by End User
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 Abbott
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Boston Scientific Corporation
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Medtronic
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 NeuroPace, Inc.
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 NeuroSigma, Inc.
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 NEVRO CORP.
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Synapse Biomedical Inc.
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Soterix Medical Inc
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Integer Holdings Corporation
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Magstim
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations
Access the Full N Market Report
Get segment-level forecasts, regional estimates, competitive benchmarking, company profiles and downloadable Excel datasets.
